empagliflozin
boehringer ingelheim,eli lilly
['empa-kidney']
today at #aha22 'meet the trialist: discussion with empa-kidney trialist' with dr david preiss 7 november 1pm cst
room: heart theater i 
Nuffield Department of Population Health | @UniofOxford | Tweets about health, our research and impact | #RECOVERYTrial